Speaker Profile
Ph.D., Medical Affairs Lead, Ataraxis AI
Biography
Anna Miller she oversees medical affairs strategy and scientific communications with clinicians. She earned her PhD in Genetics and Genomic Sciences from Case Western Reserve University in 2022, where her research focused on gene-gene and gene-environment interactions in oncology. Prior to joining Ataraxis in 2025, Anna built her expertise in oncology through prior medical affairs roles.
Talk
Ataraxis: Clinical Intelligence Through AI World Models
Ataraxis is redefining oncology through clinical intelligence powered by AI world models trained on pan-cancer datasets. By extracting novel biological features from standard H&E slides, Ataraxis delivers prognostic and predictive insights that go beyond traditional genomic assays, reshaping treatment decision-making across cancer subtypes.
AI for Clinical Decision Support Systems Showcase:
Ataraxis AI
Ataraxis harnesses AI world models trained on pan-cancer, multi-modal data to discover novel clinical, morphological, and molecular features of cancer, delivering clinical intelligence that goes beyond traditional genomic assays.
Session Abstract – PMWC 2027 Silicon Valley
The PMWC 2027 AI for Clinical Decision Support Showcase will provide a 15-30 minute time slot for selected organizations, including commercial companies, clinical testing labs, and medical research institutions, to present their latest advancements, insights, applications, and technologies to an audience of clinicians, leading investigators, academic institutions, pharma and biotech, investors, and potential clients. We will learn about new technologies and findings that promise expedited, cost-effective, and accurate clinical diagnosis for early disease detection, treatment decisions, and disease prevention.
PMWC Hall of Impact
Previous Speakers Include
Nobel laureates, technology founders, regulators, CEOs and scientific pioneers who have taken the PMWC stage.
